Cutaneous Anthrax: What is the Hallmark?
Keywords:
anthrax, human, animalAbstract
A 71-year-old man complained of a blackish wound under his left eye, which began with fever and reddish spots after helping to slaughter a cow and cut its meat. The fever occured especially in the afternoon to evening, and is not accompanied by chills and sweating. On day 4 of fever onset, the fever diminished and the spots progressively widened with swelling. On day 7, the lesions on the skin became open wounds that were not purulent and did not bleed. On day 9, a blackish, painless layer appeared over the wounds and widened, further covering their surface. Upon presentation, the patient’s general condition was good, with normal vital signs and temperature. He presented with a solitary ulcer accompanied by edema, sized 1 cm x 3 cm, not hyperemic, firm border, flat edge, and covered with blackish eschar. Blood tests revealed normal levels of hemoglobin, leukocyte, platelets, kidney and liver function. The anti-anthrax protective antigen (anti-PA) IgG level is found to be seropositive with a level of 85 U/ml. Gram staining of the tissue underneath the eschar found Gram-positive rod bacteria in reddish-purple color. The patient was clinically diagnosed with probable cutaneous anthrax, and was treated with amoxicillin 500 mg orally t.i.d. for three days and paracetamol 500 mg if fever developed. The tissue sample was sent to a laboratory with Bio Safety level 3 facilities for microbiological culture, with the results of Bacillus anthracis growth. On day three after antibiotic administration, the wound was smaller (0.5 cm x 1.5 cm), firm border, flat edge, with a bit of edema above it. The eschar was thickened, painless, not purulent nor bleeding. Antibiotic administration is continued for another three days with amoxicillin 500 mg orally t.i.d. On day 6 of antibiotic administration, the eschar began to peel off, and antibiotics were stopped. On the 10th day, the eschar peeled off entirely without leaving a mark. Early diagnosis is crucial in preventing the spread that may lead to more cases. Clinical and serological examinations are the spearheads of early detection of anthrax cases. Prompt and appropriate management largely determines the success of therapy.References
Mahmoudi H. Cutaneous anthrax in a farmer man: A case report. Open Microbiol J. 2022;16(1):2–4.
Doganay M, Dinc G, Kutmanova A, Baillie L. Human anthrax: Update of the diagnosis and treatment. Diagnostics (Basel). 2023;13(6):1056.
Savransky V, Ionin B, Reece J. Current status and trends in prophylaxis and management of anthrax disease. Pathogens. 2020; 9(5):370.
Riswanto R, Redhono D, Nurhayatun E. Antraks kulit di Gunung Kidul, Yogyakarta: Laporan kasus. J Penyakit Dalam Indonesia. 2021;8(3):151.
Redhono D, Agung N, Andika F, Sunarso I, Kusumawardani A, Dasa A. Indirect contact increases antibody titers in people exposed to anthrax. GSC Biological and Pharmaceutical Sciences. 2023; 25(02):405–10.
Celik E, Gonen T. Cutaneous anthrax on the upper eyelid. Case Rep Ophthalmol. 2021;12(3):836–40.
Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. Anthrax infection. American Journal of Respiratory and Critical Care Medicine. 2011;184(12):1333-41.
Liu Y, Zheng G, Li J, et al. A case report of cutaneous anthrax diagnosed by using a metagenomic next-generation sequencing (mNGS) approach. Infect Drug Resist. 2023;16:3601–6.
Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. Journal of Infection and Public Health. 2010;3(3):98-105.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
